Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
Journal
The New England journal of medicine
ISSN: 1533-4406
Titre abrégé: N Engl J Med
Pays: United States
ID NLM: 0255562
Informations de publication
Date de publication:
08 04 2021
08 04 2021
Historique:
pubmed:
25
2
2021
medline:
23
4
2021
entrez:
24
2
2021
Statut:
ppublish
Résumé
Most data regarding the association between the glycemic index and cardiovascular disease come from high-income Western populations, with little information from non-Western countries with low or middle incomes. To fill this gap, data are needed from a large, geographically diverse population. This analysis includes 137,851 participants between the ages of 35 and 70 years living on five continents, with a median follow-up of 9.5 years. We used country-specific food-frequency questionnaires to determine dietary intake and estimated the glycemic index and glycemic load on the basis of the consumption of seven categories of carbohydrate foods. We calculated hazard ratios using multivariable Cox frailty models. The primary outcome was a composite of a major cardiovascular event (cardiovascular death, nonfatal myocardial infarction, stroke, and heart failure) or death from any cause. In the study population, 8780 deaths and 8252 major cardiovascular events occurred during the follow-up period. After performing extensive adjustments comparing the lowest and highest glycemic-index quintiles, we found that a diet with a high glycemic index was associated with an increased risk of a major cardiovascular event or death, both among participants with preexisting cardiovascular disease (hazard ratio, 1.51; 95% confidence interval [CI], 1.25 to 1.82) and among those without such disease (hazard ratio, 1.21; 95% CI, 1.11 to 1.34). Among the components of the primary outcome, a high glycemic index was also associated with an increased risk of death from cardiovascular causes. The results with respect to glycemic load were similar to the findings regarding the glycemic index among the participants with cardiovascular disease at baseline, but the association was not significant among those without preexisting cardiovascular disease. In this study, a diet with a high glycemic index was associated with an increased risk of cardiovascular disease and death. (Funded by the Population Health Research Institute and others.).
Sections du résumé
BACKGROUND
Most data regarding the association between the glycemic index and cardiovascular disease come from high-income Western populations, with little information from non-Western countries with low or middle incomes. To fill this gap, data are needed from a large, geographically diverse population.
METHODS
This analysis includes 137,851 participants between the ages of 35 and 70 years living on five continents, with a median follow-up of 9.5 years. We used country-specific food-frequency questionnaires to determine dietary intake and estimated the glycemic index and glycemic load on the basis of the consumption of seven categories of carbohydrate foods. We calculated hazard ratios using multivariable Cox frailty models. The primary outcome was a composite of a major cardiovascular event (cardiovascular death, nonfatal myocardial infarction, stroke, and heart failure) or death from any cause.
RESULTS
In the study population, 8780 deaths and 8252 major cardiovascular events occurred during the follow-up period. After performing extensive adjustments comparing the lowest and highest glycemic-index quintiles, we found that a diet with a high glycemic index was associated with an increased risk of a major cardiovascular event or death, both among participants with preexisting cardiovascular disease (hazard ratio, 1.51; 95% confidence interval [CI], 1.25 to 1.82) and among those without such disease (hazard ratio, 1.21; 95% CI, 1.11 to 1.34). Among the components of the primary outcome, a high glycemic index was also associated with an increased risk of death from cardiovascular causes. The results with respect to glycemic load were similar to the findings regarding the glycemic index among the participants with cardiovascular disease at baseline, but the association was not significant among those without preexisting cardiovascular disease.
CONCLUSIONS
In this study, a diet with a high glycemic index was associated with an increased risk of cardiovascular disease and death. (Funded by the Population Health Research Institute and others.).
Identifiants
pubmed: 33626252
doi: 10.1056/NEJMoa2007123
doi:
Substances chimiques
Dietary Carbohydrates
0
Dietary Sugars
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1312-1322Investigateurs
S Yusuf
(S)
S Rangarajan
(S)
K K Teo
(KK)
S S Anand
(SS)
C K Chow
(CK)
M O'Donnell
(M)
A Mente
(A)
D Leong
(D)
A Smyth
(A)
P Joseph
(P)
M Duong
(M)
R D'Souza
(R)
M Walli-Attaei
(M)
S Islam
(S)
W Hu
(W)
C Ramasundarahettige
(C)
P Sheridan
(P)
S Bangdiwala
(S)
L Dyal
(L)
B Liu
(B)
C Tang
(C)
X Yang
(X)
R Zhao
(R)
L Farago
(L)
M Zarate
(M)
J Godreault
(J)
M Haskins
(M)
M Jethva
(M)
G Rigitano
(G)
A Vaghela
(A)
M Dehghan
(M)
A Aliberti
(A)
A Reyes
(A)
A Zaki
(A)
B Connolly
(B)
B Zhang
(B)
D Agapay
(D)
D Krol
(D)
E McNeice
(E)
E Ramezani
(E)
F Shifaly
(F)
G McAlpine
(G)
I Kay
(I)
J Rimac
(J)
J Swallow
(J)
M Di Marino
(M)
M Jakymyshyn
(M)
Ma Mushtaha
(M)
Mo Mushtaha
(M)
M Trottier
(M)
N Aoucheva
(N)
N Kandy
(N)
P Mackie
(P)
R Buthool
(R)
R Patel
(R)
R Solano
(R)
S Gopal
(S)
S Ramacham
(S)
S Trottier
(S)
M McQueen
(M)
S Lamers
(S)
J Keys
(J)
X Wang
(X)
A Devanath
(A)
R Diaz
(R)
A Orlandini
(A)
P Lamelas
(P)
M L Diaz
(ML)
A Pascual
(A)
M Salvador
(M)
C Chacon
(C)
O Rahman
(O)
R Yusuf
(R)
S A K S Ahmed
(SAKS)
T Choudhury
(T)
M Sintaha
(M)
A Khan
(A)
O Alam
(O)
N Nayeem
(N)
S N Mitra
(SN)
F Pasha
(F)
A Avezum
(A)
C S Marcilio
(CS)
A C Mattos
(AC)
G B Oliveira
(GB)
K Teo
(K)
Sumathy Rangarajan
(S)
A Arshad
(A)
B Bideri
(B)
G Dagenais
(G)
P Poirier
(P)
G Turbide
(G)
A S Bourlaud
(AS)
A LeBlanc De Bluts
(A)
M Cayer
(M)
I Tardif
(I)
M Pettigrew
(M)
S Lear
(S)
V de Jong
(V)
A N Saidy
(AN)
V Kandola
(V)
E Corber
(E)
I Vukmirovich
(I)
D Gasevic
(D)
A Wielgosz
(A)
A Pipe
(A)
A Lefebvre
(A)
A Pepe
(A)
A Auclair
(A)
A Prémont
(A)
A S Bourlaud
(AS)
F Lanas
(F)
P Serón
(P)
M J Oliveros
(MJ)
F Cazor
(F)
Y Palacios
(Y)
Liu Lisheng
(L)
Li Wei
(L)
Chen Chunming
(C)
Zhao Wenhua
(Z)
Hu Bo
(H)
Yin Lu
(Y)
Zhu Jun
(Z)
Liang Yan
(L)
Sun Yi
(S)
Wang Yang
(W)
Deng Qing
(D)
Jia Xuan
(J)
He Xinye
(H)
Zhang Hongye
(Z)
Bo Jian
(B)
Wang Xingyu
(W)
Liu Xu
(L)
Gao Nan
(G)
Bai Xiulin
(B)
Yao Chenrui
(Y)
Cheng Xiaoru
(C)
Wang Chuangshi
(W)
Li Sidong
(L)
Liu Weida
(L)
Lang Xinyue
(L)
Liu Xiaoyun
(L)
Zhu Yibing
(Z)
Xie Liya
(X)
Liu Zhiguang
(L)
Ren Yingjuan
(R)
Dai Xi
(D)
Gao Liuning
(G)
Wang Liping
(W)
Su Yuxuan
(S)
Han Guoliang
(H)
Song Rui
(S)
Cao Zhuangni
(C)
Sun Yaya
(S)
Li Xiangrong
(L)
Wang Jing
(W)
Wang Li
(W)
Peng Ya
(P)
Li Xiaoqing
(L)
Li Ling
(L)
Wang Jia
(W)
Zou Jianmei
(Z)
Gao Fan
(G)
Tian Shaofang
(T)
Liu Lifu
(L)
Li Yongmei
(L)
Bi Yanhui
(B)
Li Xin
(L)
Zhang Anran
(Z)
Wu Dandan
(W)
Cheng Ying
(C)
Xiao Yize
(X)
Lu Fanghong
(L)
Li Yindong
(L)
Hou Yan
(H)
Zhang Liangqing
(Z)
Guo Baoxia
(G)
Liao Xiaoyang
(L)
Chen Di
(C)
Zhang Peng
(Z)
Li Ning
(L)
Ma Xiaolan
(M)
Lei Rensheng
(L)
Fu Minfan
(F)
Liu Yu
(L)
Xing Xiaojie
(X)
Yang Youzhu
(Y)
Zhao Shenghu
(Z)
Xiang Quanyong
(X)
Tang Jinhua
(T)
Liu Zhengrong
(L)
Qiang Deren
(Q)
Li Xiaoxia
(L)
Xu Zhengting
(X)
Aideeraili Ayoupu
(A)
Zhao Qian
(Z)
P Lopez-Jaramillo
(P)
P A Camacho-Lopez
(PA)
M Perez
(M)
J Otero-Wandurraga
(J)
D I Molina
(DI)
C Cure-Cure
(C)
J L Accini
(JL)
E Hernandez
(E)
E Arcos
(E)
C Narvaez
(C)
A Sotomayor
(A)
F Manzur
(F)
H Garcia
(H)
G Sanchez
(G)
F Cotes
(F)
A Rico
(A)
M Duran
(M)
C Torres
(C)
P Mony
(P)
M Vaz
(M)
S Swaminathan
(S)
A V Bharathi
(AV)
K Shankar
(K)
A V Kurpad
(AV)
K G Jayachitra
(KG)
H A L Hospital
(HAL)
A R Raju
(AR)
S Niramala
(S)
V Hemalatha
(V)
K Murali
(K)
C Balaji
(C)
A Janaki
(A)
K Amaranadh
(K)
P Vijayalakshmi
(P)
V Mohan
(V)
R M Anjana
(RM)
M Deepa
(M)
K Parthiban
(K)
L Dhanasekaran
(L)
S K Sundaram
(SK)
M Rajalakshmi
(M)
P Rajaneesh
(P)
K Munusamy
(K)
M Anitha
(M)
S Hemavathy
(S)
T Rahulashankiruthiyayan
(T)
D Anitha
(D)
R Dhanasekar
(R)
S Sureshkumar
(S)
K Sridevi
(K)
R Gupta
(R)
R B Panwar
(RB)
I Mohan
(I)
P Rastogi
(P)
S Rastogi
(S)
R Bhargava
(R)
M Sharma
(M)
D Sharma
(D)
V Raman Kutty
(V)
K Vijayakumar
(K)
S Nair
(S)
R Kamala
(R)
M S Manu
(MS)
A R Arunlal
(AR)
A Veena
(A)
Sandeep P Kumar
(SP)
Leena Kumari
(L)
R Tessi
(R)
S Jith
(S)
K Ajayan
(K)
G Rajasree
(G)
A R Renjini
(AR)
A Deepu
(A)
B Sandhya
(B)
S Asha
(S)
H S Soumya
(HS)
R Kumar
(R)
M Kaur
(M)
P V M Lakshmi
(PVM)
V Sagar
(V)
J S Thakur
(JS)
B Patro
(B)
R Mahajan
(R)
A Josh
(A)
G Singh
(G)
K Sharma
(K)
P Chaudary
(P)
R Kelishadi
(R)
A Bahonar
(A)
N Mohammadifard
(N)
H Heidari
(H)
K Davletov
(K)
B Assembekov
(B)
B Amirov
(B)
E Mirrakhimov
(E)
S Abilova
(S)
U Zakirov
(U)
U Toktomamatov
(U)
K Yusoff
(K)
T S Ismail
(TS)
K Ng
(K)
A Devi
(A)
N Mat-Nasir
(N)
A S Ramli
(AS)
M N K Nor-Ashikin
(MNK)
R Dasiman
(R)
M Y Mazapuspavina
(MY)
F Ariffin
(F)
M Miskan
(M)
H Abdul-Hamid
(H)
S Abdul-Razak
(S)
N Baharudin
(N)
N M N Mohd-Nasir
(NMN)
S F Badlishah-Sham
(SF)
M S Mohamed-Yassin
(MS)
M Koshy
(M)
F A Majid
(FA)
N A Bakar
(NA)
N Zainon
(N)
R Salleh
(R)
S R Norlizan
(SR)
N M Ghazali
(NM)
M Baharom
(M)
H Zulkifli
(H)
R Razali
(R)
S Ali
(S)
C W J C W Hafar
(CWJCW)
F Basir
(F)
Noorhassim Ismail
(N)
M J Hasni
(MJ)
M T Azmi
(MT)
M I Zaleha
(MI)
R Ismail
(R)
K Y Hazdi
(KY)
N Saian
(N)
A Jusoh
(A)
N Nasir
(N)
A Ayub
(A)
N Mohamed
(N)
A Jamaludin
(A)
Z Rahim
(Z)
R Khatib
(R)
U Khammash
(U)
R Giacaman
(R)
R Iqbal
(R)
R Khawaja
(R)
I Azam
(I)
K Kazmi
(K)
J Miranda
(J)
A Bernabe Ortiz
(A)
W Checkley
(W)
R H Gilman
(RH)
L Smeeth
(L)
R M Carrillo
(RM)
M de Los Angeles
(M)
C Tarazona Meza
(C)
A Dans
(A)
H U Co
(HU)
J T Sanchez
(JT)
L Pudol
(L)
C Zamora-Pudol
(C)
L A M Palileo-Villanueva
(LAM)
M R Aquino
(MR)
C Abaquin
(C)
S L Pudol
(SL)
K Manguiat
(K)
S Malayang
(S)
W Zatonski
(W)
A Szuba
(A)
K Zatonska
(K)
R Ilow
(R)
M Ferus
(M)
B Regulska-Ilow
(B)
D Różańska
(D)
M Wolyniec
(M)
K F Alhabib
(KF)
M Alshamiri
(M)
H B Altaradi
(HB)
O Alnobani
(O)
N Alkamel
(N)
M Ali
(M)
M Abdulrahman
(M)
R Nouri
(R)
L Kruger
(L)
A Kruger
(A)
P Bestra
(P)
H Voster
(H)
A E Schutte
(AE)
E Wentzel-Viljoen
(E)
F C Eloff
(FC)
H de Ridder
(H)
H Moss
(H)
J Potgieter
(J)
A Roux
(A)
M Watson
(M)
G de Wet
(G)
A Olckers
(A)
J C Jerling
(JC)
M Pieters
(M)
T Hoekstra
(T)
T Puoane
(T)
R Swart
(R)
E Igumbor
(E)
L Tsolekile
(L)
K Ndayi
(K)
D Sanders
(D)
P Naidoo
(P)
N Steyn
(N)
N Peer
(N)
B Mayosi
(B)
B Rayner
(B)
V Lambert
(V)
N Levitt
(N)
T Kolbe-Alexander
(T)
L Ntyintyane
(L)
G Hughes
(G)
J Fourie
(J)
M Muzigaba
(M)
S Xapa
(S)
N Gobile
(N)
B Jwili
(B)
K Ndibaza
(K)
B Egbujie
(B)
A Rosengren
(A)
K Bengtsson Boström
(K)
A Rawshani
(A)
A Gustavsson
(A)
M Andreasson
(M)
L Wirdemann
(L)
K Yeates
(K)
M Oresto
(M)
N West
(N)
A Oguz
(A)
N Imeryuz
(N)
Y Altuntas
(Y)
S Gulec
(S)
A Temizhan
(A)
K Karsidag
(K)
K B T Calik
(KBT)
A K Akalin
(AK)
O T Caklili
(OT)
M V Keskinler
(MV)
K Yildiz
(K)
A Yusufali
(A)
F Hussain
(F)
M H S Abdelmotagali
(MHS)
D F Youssef
(DF)
O Z S Ahmad
(OZS)
F H M Hashem
(FHM)
T M Mamdouh
(TM)
F M AbdRabbou
(FM)
S H Ahmed
(SH)
M A AlOmairi
(MA)
H M Swidan
(HM)
M Omran
(M)
N A Monsef
(NA)
J Chifamba
(J)
T Ncube
(T)
B Ncube
(B)
C Chimhete
(C)
G K Neya
(GK)
T Manenji
(T)
L Gwaunza
(L)
V Mapara
(V)
G Terera
(G)
C Mahachi
(C)
P Murambiwa
(P)
R Mapanga
(R)
A Chinhara
(A)
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2021 Massachusetts Medical Society.